Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(12.35) per share which missed the analyst consensus estimate of $(8.40) by 47.02 percent. This is a 3.21 percent increase over losses of $(12.76) per share from the same period last year. The company reported quarterly sales of $1.279 million which missed the analyst consensus estimate of $1.540 million by 16.95 percent. This is a 126.77 percent increase over sales of $564.000 thousand the same period last year.